TWST
NASDAQTwist Bioscience Corporation
Price$69.11+21.01 (+43.67%)
2026-03-042026-06-05
News · 26 weeks106-30%
2025-12-142026-06-07
Mix4990d
- Insider35(71%)
- SEC Filings7(14%)
- Other4(8%)
- Earnings2(4%)
- Analyst1(2%)
Latest news
25 items- INSIDERChief Financial Officer Laponis Adam sold $280,000 worth of shares (4,000 units at $70.00) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 112,675 units (SEC Form 4)4 - Twist Bioscience Corp (0001581280) (Issuer)
- INSIDEROfficer Cho Dennis sold $990,799 worth of shares (14,205 units at $69.75) as part of a pre-agreed trading plan, decreasing direct ownership by 11% to 120,094 units (SEC Form 4)4 - Twist Bioscience Corp (0001581280) (Issuer)
- INSIDERDirector Starovasnik Melissa A. sold $170,000 worth of shares (2,500 units at $68.00) as part of a pre-agreed trading plan, decreasing direct ownership by 10% to 22,222 units (SEC Form 4)4 - Twist Bioscience Corp (0001581280) (Issuer)
- INSIDERChief Executive Officer Leproust Emily M. exercised 16,470 shares at a strike of $8.82 and sold $1,118,555 worth of shares (16,470 units at $67.91) as part of a pre-agreed trading plan (SEC Form 4)4 - Twist Bioscience Corp (0001581280) (Issuer)
- INSIDERChief Accounting Officer Werner Robert F. sold $49,987 worth of shares (800 units at $62.48), decreasing direct ownership by 2% to 48,186 units (SEC Form 4) (tax liability)4 - Twist Bioscience Corp (0001581280) (Issuer)
- INSIDERChief Executive Officer Leproust Emily M. exercised 49,299 shares at a strike of $8.82 and sold $3,213,653 worth of shares (49,299 units at $65.19) as part of a pre-agreed trading plan (SEC Form 4)4 - Twist Bioscience Corp (0001581280) (Issuer)
- INSIDERDirector Starovasnik Melissa A. sold $30,520 worth of shares (500 units at $61.04) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 24,722 units (SEC Form 4)4 - Twist Bioscience Corp (0001581280) (Issuer)
- PRTwist Bioscience to Present at William Blair 46th Annual Growth Stock ConferenceTwist Bioscience Corporation (NASDAQ:TWST), a mid-cap growth and value biotech company, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience and Adam Laponis, CFO of Twist Bioscience will present at the William Blair 46th Annual Growth Stock Conference on Tuesday, June 2, 2026 at 10:00 am Central Time in Chicago, Illinois. The presentation will be webcast live and can be accessed by visiting the "Investor Calendar" page of the investor relations section of the company's website here. A replay of the presentation will be archived for a period of 30 days following the conclusion of the live events. About Twist Bioscience Corporation At Twist Bioscience,
- INSIDERSVP of Human Resources Green Paula sold $74,507 worth of shares (1,399 units at $53.26), decreasing direct ownership by 1% to 121,589 units (SEC Form 4) (for tax liability)4 - Twist Bioscience Corp (0001581280) (Issuer)
- INSIDERPresident and COO Finn Patrick John sold $221,549 worth of shares (4,160 units at $53.26), decreasing direct ownership by 1% to 274,804 units (SEC Form 4) (withholding obligation)4 - Twist Bioscience Corp (0001581280) (Issuer)
- INSIDEROfficer Cho Dennis sold $87,448 worth of shares (1,642 units at $53.26), decreasing direct ownership by 1% to 134,299 units (SEC Form 4) (withholding tax)4 - Twist Bioscience Corp (0001581280) (Issuer)
- INSIDERChief Financial Officer Laponis Adam sold $107,526 worth of shares (2,019 units at $53.26), decreasing direct ownership by 2% to 116,675 units (SEC Form 4) to satisfy withholding tax4 - Twist Bioscience Corp (0001581280) (Issuer)
- INSIDERChief Accounting Officer Werner Robert F. sold $36,641 worth of shares (688 units at $53.26), decreasing direct ownership by 1% to 48,986 units (SEC Form 4) (for withholding tax)4 - Twist Bioscience Corp (0001581280) (Issuer)
- INSIDERChief Executive Officer Leproust Emily M. sold $366,834 worth of shares (6,888 units at $53.26), decreasing direct ownership by 0.81% to 846,872 units (SEC Form 4) (tax liability)4 - Twist Bioscience Corp (0001581280) (Issuer)
- INSIDERDirector Johannessen Jan exercised 12,000 shares at a strike of $14.00 and sold $673,440 worth of shares (12,000 units at $56.12) (SEC Form 4)4 - Twist Bioscience Corp (0001581280) (Issuer)
- INSIDERChief Accounting Officer Werner Robert F. sold $282,187 worth of shares (4,961 units at $56.88), decreasing direct ownership by 9% to 49,674 units (SEC Form 4)4 - Twist Bioscience Corp (0001581280) (Issuer)
- SECSEC Form 144 filed by Twist Bioscience Corporation144 - Twist Bioscience Corp (0001581280) (Subject)
- INSIDEROfficer Cho Dennis sold $112,126 worth of shares (1,962 units at $57.15), decreasing direct ownership by 1% to 135,941 units (SEC Form 4) to satisfy tax liability4 - Twist Bioscience Corp (0001581280) (Issuer)
- INSIDERChief Executive Officer Leproust Emily M. sold $293,002 worth of shares (5,127 units at $57.15), decreasing direct ownership by 0.60% to 853,760 units (SEC Form 4) (for tax liability)4 - Twist Bioscience Corp (0001581280) (Issuer)
- INSIDERChief Accounting Officer Werner Robert F. sold $9,372 worth of shares (164 units at $57.15), decreasing direct ownership by 0.30% to 54,635 units (SEC Form 4) to cover taxes4 - Twist Bioscience Corp (0001581280) (Issuer)
- INSIDERPresident and COO Finn Patrick John sold $162,531 worth of shares (2,844 units at $57.15), decreasing direct ownership by 1% to 278,964 units (SEC Form 4) to satisfy tax liability4 - Twist Bioscience Corp (0001581280) (Issuer)
- INSIDERSVP of Human Resources Green Paula sold $63,778 worth of shares (1,116 units at $57.15), decreasing direct ownership by 0.90% to 122,988 units (SEC Form 4) (withholding obligation)4 - Twist Bioscience Corp (0001581280) (Issuer)
- PRTwist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ:TWST) ("Twist" or the "Company"), a mid-cap growth and value biotech company, today announced that a total of 115,279 equity awards, consisting of 101,931 restricted stock units ("RSUs") and up to 13,348 performance stock units ("PSUs"), will be granted to 53 recently hired individuals, in each case as an inducement material to their acceptance of employment with Twist. The employment inducement awards will be granted under Twist's Amended and Restated Inducement Equity Incentive Plan and related form of restricted stock unit award agreement in accordance with Nasdaq Listing Rule 5635(c)(4). The indu
- ANALYSTTwist Bioscience upgraded by Leerink Partners with a new price targetLeerink Partners upgraded Twist Bioscience from Market Perform to Outperform and set a new price target of $70.00
- SECSEC Form 10-Q filed by Twist Bioscience Corporation10-Q - Twist Bioscience Corp (0001581280) (Filer)
TWST FAQ
7 questionsWhat does Twist Bioscience Corporation do?
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has collaboration agreements with ImmunoPrecise Antibodies Ltd.; Victorian Clinical Genetic Services; Vivlion GmbH; and Kyowa Kirin Pharmaceutical Research, Inc. Twist...Where does TWST stock trade?
Twist Bioscience Corporation (TWST) is listed on NASDAQ.What sector and industry is TWST in?
Twist Bioscience Corporation operates in the Health Care sector, Biotechnology: Biological Products (No Diagnostic Substances) industry.When did Twist Bioscience Corporation go public?
Twist Bioscience Corporation (TWST) completed its IPO in 2018.What are analysts saying about TWST?
Twist Bioscience Corporation has had 8 recent analyst actions on file. The most recent action was from Leerink Partners: Outperform on 2026-05-05. Recent price targets range from $2700.00 to $4500.00.What companies are similar to TWST?
Notable peers in the same industry include AMGN (Amgen Inc.), GILD (Gilead Sciences Inc.), ARGX (argenx SE), RVMD (Revolution Medicines Inc.), BIIB (Biogen Inc.). Compare TWST side-by-side with any of them on Quantisnow.How can I track TWST on Quantisnow?
Quantisnow aggregates Twist Bioscience Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow TWST to receive live email and push alerts on every new disclosure.